(Q34455140)

2 August 2017

1 reference

title

Nasopharyngeal carcinomas: analysis of patient, tumor and treatment characteristics determining outcome (English)

1 reference

2 August 2017

1 reference

Erkal HS

1

1 reference

PubMed ID

11730993

2 August 2017

Serin M

series ordinal

2

1 reference

PubMed ID

11730993

2 August 2017

Cakmak A

series ordinal

3

1 reference

2 August 2017

1 December 2001

1 reference

Radiotherapy and Oncology

2 August 2017

1 reference

2 August 2017

61

1 reference

2 August 2017

3

1 reference

2 August 2017

247-256

1 reference

2 August 2017

Nasopharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

High Complete Response in Advanced Nasopharyngeal Carcinoma With Bleomycin, Epirubicin, and Cisplatin Before Radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Carcinoma of the nasopharynx: results of radiation treatment and some prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

The role of chemotherapy in the management of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal ca

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx: preliminary corroboration of the intergroup experience

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Combined radiotherapy and chemotherapy for nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Neoadjuvant chemotherapy and radiation therapy compared with radiation therapy alone in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Nasopharyngeal carcinoma in Taiwan clinical manifestations and results of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progr

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Nasopharyngeal carcinoma: local control by megavoltage irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Estimates of the worldwide incidence of 25 major cancers in 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Carcinoma of the nasopharynx: factors affecting prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Nasopharyngeal carcinoma in childhood and adolescence.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Radiation therapy and concurrent cisplatin in management of locoregionally advanced nasopharyngeal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Nasopharyngeal carcinoma in young patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Histopathology of nasopharyngeal carcinoma.Correlations with epidemiology, survival rates and other biological characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Combined treatment in carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Prognostic factors of nasopharyngeal carcinoma: a multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Sequential chemotherapy and radiation for nasopharyngeal cancer: absence of long-term benefit despite a high rate of tumor response to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dose-tumor-control relationship above conventional tumoricidal dose.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

Synchronous radiotherapy and chemotherapy in the treatment of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900448-0

7 January 2021

10.1016/S0167-8140(01)00448-0

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11730993